You are here

TGA Internet site archive

The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.

NDPSC record of reasons, 42nd meeting, 12-14 October 2004

National Drugs and Poisons Schedule Committee

12 October 2004

The Record of the Reasons contains the basis of scheduling decisions and other outcomes arising from the meeting. Please note that the Record of the Reasons includes extracts from the NDPSC minutes which have been edited to remove confidential information.

How to access a pdf document

*Large file warning: Attempting to open large pdf files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

NDPSC Record of reasons, Meeting 42 (pdf,534kb)*

Contents

Glossary

  • 1.7.1 Opererations/Policies of the Committee
    • 1.7.1.4 Appendix E
  • 1.8 NDPSC working parties
    • 1.8.1 Trans-Tasman Harmonisation Working Party
      • 1.8.1.2 Antibiotic Substances (Nisin)
      • 1.8.1.3 Strychnos spp
      • 1.8.1.5 Salbutamol and Terbutaline
    • 1.8.2.1 Propantheline
    • 1.8.2.2 Amphotericin
  • 1.9 Proposed changes to the SUSDP
  • 2. Proposed changes/additions to Parts 1 to 3 and Part 5 of the Standard for the Uniform Scheduling of Drugs and Poisons
    • 2.1 SUSDP, Part 1
    • 2.2 SUSDP, Part 2
      • 2.2.1 Labels and containers
    • 2.3 SUSDP, Part 3

Top of page

Agricultural/Veterinary, Industrial and Domestic Chemicals

3. Matters arising from the minutes of the previous meeting (consideration of post-meeting submissions under 42ZCZ)

  • 3.1 Octenol

4. Other outstanding matters from previous meetings

  • 4.1 Eyelash and eyebrow tinting products
  • 4.2 Methylcyclopentadienyl magnesium tricarbonyl
  • 4.3 Creosote
  • 4.4 Alkaline salts
  • 4.5 Flumiclorac pentyl
  • 4.6 Permethrin
  • 4.7 Sodium hypochlorite

5. Proposed changes/additions to the Standard for the Uniform Scheduling of Drugs and Poisons

  • 5.2 SUSDP, Part 5
    • 5.2.1 Warning statements and general safety directions established by CPAS for agricultural and veterinary chemicals (standing agenda item)

6. Matters referred by the Australian Pesticides and Veterinary Medicines Authority

  • 6.1 Iminoctadine trialbesilate
  • 6.2 N-cyclohexyldiazeniumdioxy-potassium
  • 6.3 Deltamethrin
  • 6.4 Pine oils
  • 6.5 Pyrithione copper
  • 6.6 Pyraflufen ethyl
  • 6.7 Cyhalofop butyl
  • 6.8 Procymidone
  • 6.9 Butorphanol
  • 6.10-6.11 Potassium sorbate/sodium propionate

Top of page

7. Matters referred by Office of Chemical Safety (OCS)

  • 8.1 Sulfacetamide
  • 8.2-8.4 Tetracyclines

9. Other matters for consideration

10. Initial review and/or formal opinions (ag/vet, industrial & domestic chemicals)

11. Information items (ag/vet, industrial & domestic chemicals)

Top of page

Pharmaceuticals

12. Matters arising from the minutes of the previous meeting (consideration of post-meeting submissions under 42ZCZ)

  • 12.1 Porcine pancreatic enzymes
  • 12.2 Kava and kavalactones

13. Other outstanding matters from previous meetings

  • 13.1 Melia azedarach
  • 13.2 Pseudoephedrine
  • 13.3 Medical devices
  • 13.4 Aspirin
  • 13.5 Ketamine
  • 13.6 Aripiprazole
  • 13.8 Rosuvastatin
  • 13.9 Diclofenac

Top of page

14. Proposed changes/additions to the Standard for the Uniform Scheduling of Drugs and Poisons

  • 14.1 SUSDP, Part 4
    • 14.1.2 Neomycin, Polymyxin & Bacitracin
    • 14.1.3 Oseltamivir
    • 14.1.4 Silicones
  • 14.2 SUSDP, Part 5
    • 14.2.1 Appendix H

15. Matters referred by the Australian Drug Evaluation Committee (ADEC)

  • 15.1 New substances
    • 15.1.1 Disodium gadoxetate
    • 15.1.2 Fosamprenavir
    • 15.1.3 Lumiracoxib
    • 15.1.4 Carbetocin
    • 15.1.5 Pemetrexed
  • 15.2 For information (substances already scheduled)
    • 15.2.1 Ketotifen

16. Other matters for consideration

  • 16.2 Hyoscyamus niger and atropine - clarification of Schedule 2 entry
  • 16.3-16.4 2,5-Dimethoxy-4-iodophenethylamine and 5-methoxy-α-methtryptamine

17. Matters referred by the Medicines Evaluation Committee (MEC)

  • 17.1 Nicotine
  • 17.2 Quinine

18. Matters referred by the Medicines Classification Committee (MCC) of New Zealand

  • 18.1 Zinc compounds

22. Amendments to the SUSDP

  • 22.1 Editorials and errata

Top of page